iTeos Therapeutics, Inc. (ITOS) Misses Q4 EPS by 2c

iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q4 EPS of ($0.85), $0.02 worse than the analyst estimate of ($0.83).

For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.

You May Also Be Interested In

• Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
• Prenetics Global (PRE) Tops Q2 EPS by 18c
• CXApp acquires Australian firm EngineRoom in June 2026 deal